188 results
Page 7 of 10
8-K
EX-99.1
swnlgv79cmwxk4 gvd2
9 Apr 07
Discovery Labs Announces Completion of $30 Million Registered Direct Offering
12:00am
8-K
EX-99.1
5vv1c17
3 Apr 07
Discovery Labs to Raise $30 Million in Registered Direct Offering
12:00am
424B5
thd8buyu1xd70oevj
3 Apr 07
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
53e6 wlsm
28 Feb 07
Discovery Labs Reports Fourth Quarter 2006 Financial Results
12:00am
8-K
EX-99.1
6x232gfg
9 Nov 06
Discovery Labs Reports Third Quarter 2006 Financial Results
12:00am
8-K
EX-99.1
c5c6uzbn4pzt8b
26 Oct 06
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
4ya4rbbh7vym4k
11 Oct 06
Discovery Labs Announces Topline Results of Surfaxin® Phase 2 Clinical Trial for the Prevention and Treatment of BPD
12:00am
8-K
EX-99.1
nietjzsn
28 Sep 06
Discovery Labs Updates Progress on Manufacturing Remediation and Surfaxin® FDA Regulatory Matters
12:00am
8-K
EX-99.1
dnq1m9dvgmuqdhky55
2 Aug 06
Discovery Labs Reports Second Quarter 2006 Financial Results
12:00am
8-K
EX-99.1
yet2f1hka5p0dqzrwje3
27 Jun 06
Discovery Labs Reports Progress on its Surfactant Manufacturing Remediation
12:00am
8-K
EX-99.1
glhtelba
22 Jun 06
Discovery Labs Retains Jefferies & Company to Assist in the Evaluation of Potential Strategic Alternatives
12:00am
8-K
EX-99.1
7smqwlzk
16 Jun 06
Discovery Labs’ SurfaxinÒ Granted Orphan Drug Designation for the Prevention of Bronchopulmonary Dysplasia
12:00am
8-K
EX-99.1
570ftpf
7 Jun 06
Other Events
12:00am
424B3
wqje 9dk4n
12 May 06
Prospectus supplement
12:00am
8-K
EX-99.1
2g7eg3 itg
4 May 06
Discovery Labs Announces Corporate Reorganization and Personnel Reduction
12:00am